Omni Partners LLP Takes Position in Envision Healthcare Corp (EVHC)
Omni Partners LLP acquired a new stake in Envision Healthcare Corp (NYSE:EVHC) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 347,674 shares of the company’s stock, valued at approximately $15,301,000. Envision Healthcare makes up 1.7% of Omni Partners LLP’s portfolio, making the stock its 13th biggest holding. Omni Partners LLP owned 0.29% of Envision Healthcare at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. Chicago Capital Management LLC bought a new stake in shares of Envision Healthcare in the 2nd quarter valued at $21,283,000. Principal Financial Group Inc. increased its stake in shares of Envision Healthcare by 2.5% in the 1st quarter. Principal Financial Group Inc. now owns 205,812 shares of the company’s stock valued at $7,909,000 after acquiring an additional 4,951 shares in the last quarter. Boston Partners increased its stake in shares of Envision Healthcare by 1.7% in the 2nd quarter. Boston Partners now owns 1,037,548 shares of the company’s stock valued at $45,662,000 after acquiring an additional 16,991 shares in the last quarter. S. Muoio & CO. LLC bought a new stake in shares of Envision Healthcare in the 2nd quarter valued at $2,201,000. Finally, American Century Companies Inc. bought a new stake in shares of Envision Healthcare in the 1st quarter valued at $4,960,000.
Shares of EVHC stock opened at $45.56 on Thursday. The firm has a market cap of $5.51 billion, a price-to-earnings ratio of 18.37, a price-to-earnings-growth ratio of 1.16 and a beta of 0.34. The company has a debt-to-equity ratio of 0.87, a current ratio of 2.44 and a quick ratio of 2.42. Envision Healthcare Corp has a 12 month low of $23.77 and a 12 month high of $50.37.
Several research firms have recently weighed in on EVHC. Zacks Investment Research upgraded shares of Envision Healthcare from a “hold” rating to a “buy” rating and set a $51.00 price objective for the company in a research note on Friday, September 7th. Robert W. Baird lowered shares of Envision Healthcare from an “outperform” rating to a “neutral” rating in a research note on Monday, June 11th. William Blair lowered shares of Envision Healthcare from an “outperform” rating to a “market perform” rating in a research note on Monday, June 11th. Raymond James restated a “market perform” rating and set a $51.00 price target on shares of Envision Healthcare in a research note on Tuesday, June 12th. Finally, Cantor Fitzgerald restated a “hold” rating and set a $46.00 price target on shares of Envision Healthcare in a research note on Friday, August 10th. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and five have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $42.28.
Envision Healthcare Company Profile
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
Read More: Earnings Per Share
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Corp (NYSE:EVHC).
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.